Dan Liu | Medicine and Dentistry | Best Researcher Award

Posted on 20/11/202420/11/2024 by Book of Award

Dr. Dan Liu | Medicine and Dentistry | Best Researcher Award

General Hospital of Ningxia Medical University | China

Author Profile

🌱 Early Academic Pursuits

Dr. Dan Liu began her distinguished journey with a strong foundation in medicine and research. Her academic rigor led her to advanced positions, including her role as a doctoral supervisor and principal investigator. She gained international exposure as a visiting scholar at the University of Iowa and Texas Medical Center, further enhancing her global perspective and expertise in medical sciences.

💼 Professional Endeavors

Currently, Dr. Liu serves as the director of the Ningxia Hysteroscopy Diagnosis and Treatment Center and plays a pivotal role at the General Hospital of Ningxia Medical University. Her leadership in hysteroscopy diagnostics has transformed the medical landscape in Ningxia. Beyond clinical duties, she actively drives innovation and research, influencing medical sciences both regionally and nationally.

🔬 Contributions and Research Focus

Dr. Liu's research portfolio is impressive, including two projects funded by the National Natural Science Foundation of China and one significant national-grade project. She has successfully integrated technological advancements into her field, holding one utility model patent and one invention patent. Her pioneering contributions address critical challenges in women’s health, making significant strides in hysteroscopy techniques and diagnostics.

🏆 Accolades and Recognition

Dr. Liu’s accomplishments have garnered numerous awards, such as the prestigious second prize of the Science and Technology Progress Award of Ningxia Autonomous Region. In 2023, her dedication and exceptional service earned her the "Special Contribution" Award from People’s Daily Online, recognizing her as an excellent doctor. These accolades underscore her impact on medical innovation and patient care.

🌟 Impact and Influence

Through her dual roles in clinical practice and academia, Dr. Liu has shaped the next generation of medical professionals while advancing the field of hysteroscopy. Her leadership in research and treatment has set new benchmarks, directly benefiting patients and fostering a culture of innovation in the medical community.

🔮 Legacy and Future Contributions

As a trailblazer in her field, Dr. Liu’s legacy is one of excellence and commitment to advancing healthcare. Her ongoing projects and visionary leadership promise continued contributions to medical science, inspiring future researchers and clinicians to follow her path of innovation and service.

Publications

📝 Meta-analysis of FOXP3 polymorphisms and recurrent spontaneous abortion susceptibility
Authors: Shuai, R., Li, D., Xu, X., Yang, X., Liu, D.
Journal: American Journal of Reproductive Immunology
Year: 2024

📝 The osteogenesis and the biologic mechanism of thermo-responsive injectable hydrogel containing carboxymethyl chitosan/sodium alginate nanoparticles towards promoting osteal wound healing
Authors: Shi, Z., Yang, F., Pang, Q., Zhu, Y.
Journal: International Journal of Biological Macromolecules
Year: 2023

📝 Bone marrow mesenchymal stem cells combined with estrogen synergistically promote endometrial regeneration and reverse EMT via Wnt/β-catenin signaling pathway
Authors: Yuan, L., Cao, J., Hu, M., Chen, M., Liu, D.
Journal: Reproductive Biology and Endocrinology
Year: 2022

📝 A novel intrauterine barrier for preventing the recurrence of IUA after TCRA procedure
Authors: Chen, M., Yuan, L., Jin, H., Zhang, X., Liu, D.
Journal: Medical Hypotheses
Year: 2022

📝 Organoid Transplantation Can Improve Reproductive Prognosis by Promoting Endometrial Repair in Mice
Authors: Zhang, H., Xu, D., Li, Y., Li, G., Liu, D.
Journal: International Journal of Biological Sciences
Year: 2022

Yanhua Wang | Medicine and Dentistry | Best Researcher Award

Posted on 18/11/202418/11/2024 by Book of Award

Dr. Yanhua Wang | Medicine and Dentistry | Best Researcher Award

Shanxi Aier Eye Hospital | China

Author Profile

Scopus

Orcid

Early Academic Pursuits 📚

Dr. Yanhua Wang's journey in ophthalmology began with her Bachelor's degree in Clinical Medicine from Shanxi Changzhi Medical University in 1998. She pursued advanced studies, earning an MD in Ophthalmology and a PhD from Southwest Eye Hospital, General Medical University in Chongqing, China. Her academic trajectory was further enriched with a postdoctoral fellowship at the Department of Ophthalmology, General Hospital of PLA, Beijing, in 2013. This solid foundation equipped her with expertise in cutting-edge ophthalmic research and clinical care.

Professional Endeavors 💼

Dr. Wang's career spans over two decades, marked by her tenure as Deputy Chief Physician at Jinhzhong Hospital, Shanxi Province, where she served until 2016. Currently, she is the Chief Physician at the Department of Pediatric Ophthalmology & Optometry, Shanxi Aier Eye Hospital, part of the Aier Eye Hospital Group. Her role emphasizes innovative treatments and advanced care for pediatric ocular conditions, solidifying her as a leader in her field.

Contributions and Research Focus 🧠🔬

Dr. Wang’s research delves into the mechanisms underlying retinal neuron survival, optic nerve regeneration, and pediatric strabismus. Her studies on alpha-crystallin’s neuroprotective effects and its role in axonal regeneration have pioneered new therapeutic pathways. Through publications in journals such as Journal of Ophthalmology and Neuroscience Letters, she has significantly advanced understanding in these domains. She has also innovated patented technologies, including intelligent examination devices and surgical support structures, showcasing her dedication to translational research.

Accolades and Recognition 🏆

Dr. Wang has received numerous accolades, including the Chongqing Second Prize for Scientific and Technological Progress in 2013. She has secured major grants from prestigious institutions, such as the National Natural Science Foundation of China, the China Postdoctoral Science Foundation, and the Aier Eye Hospital Group Foundation. These honors reflect her impactful contributions to ophthalmology and translational medicine.

Impact and Influence 🌍

Dr. Wang’s work has had a profound influence on pediatric ophthalmology, offering novel diagnostic and therapeutic solutions for conditions like strabismus. Her patented inventions have enhanced clinical precision and patient outcomes, and her research has provided valuable insights into neuroprotection and nerve regeneration. Her leadership in clinical care and her scientific achievements continue to inspire and guide the next generation of ophthalmologists.

Legacy and Future Contributions 🌟

With her unwavering commitment to pediatric ophthalmology and groundbreaking research, Dr. Yanhua Wang's legacy is one of innovation and compassion. Her future contributions promise to bridge clinical advancements with cutting-edge research, ensuring better ocular health outcomes for children worldwide. Through her continued efforts, Dr. Wang is poised to leave an indelible mark on ophthalmology and medical science.

Publications

📝 Characteristics of Peripheral Retinal Refraction and Its Role in Children with Different Refractive States
Authors: Qi Zhao, Yanhua Wang*, Tiangang Liang, Weixiang Nie, Pei Xue, Jie Cheng
Journal: Journal of Ophthalmology
Year: 2024

📝 Synergistic Effect of Olfactory Ensheathing Cells and Alpha-Crystallin on Restoration of Adult Rat Optic Nerve Injury
Authors: Wang, Y.H., Yin, Z.Q., Wang, Y.
Journal: Neuroscience Letters
Year: 2017

📝 Leber's Hereditary Optic Neuropathy is Associated with Compound Primary Mutations of Mitochondrial ND1 m.3635G > A and ND6 m.14502 T > C
Authors: Jin, X., Wang, L., Gong, Y., Chen, T., Wei, S.
Journal: Ophthalmic Genetics
Year: 2015

📝 Alpha-Crystallin Promotes Rat Olfactory Ensheathing Cells Survival and Proliferation through Regulation of PI3K/Akt/mTOR Signaling Pathways
Authors: Wang, Y.H., Li, Y.C., Huo, S.J., Yin, Z.Q.
Journal: Neuroscience Letters
Year: 2012

📝 Alpha-Crystallin Promotes Rat Axonal Regeneration through Regulation of RhoA/Rock/Cofilin/MLC Signaling Pathways
Authors: Wang, Y.H., Wang, D.W., Wu, N., Wang, Y., Yin, Z.Q.
Journal: Journal of Molecular Neuroscience
Year: 2012

Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

Posted on 13/11/202413/11/2024 by Book of Award

Dr. Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

FAES Farma | Spain

Author Profile

Scopus

🌱 Early Academic Pursuits

Dr. Inmaculada Gilaberte’s academic journey is rooted in a commitment to excellence and medical advancement. She initially pursued education in clinical research, equipping herself with in-depth knowledge and skills in therapeutic areas such as neuroscience and immunology. Her academic foundation was further strengthened by certifications, including a lecturer certification from the Spanish Quality Register Agency (ANECA), and advanced leadership programs from institutions like Stanford and MIT. These formative experiences shaped her growth mindset, laying the groundwork for a career dedicated to precision, patient-centered care, and effective team collaboration.

💼 Professional Endeavors

Throughout her career, Dr. Gilaberte has held prominent roles in major pharmaceutical companies such as FAES FARMA, Takeda, TiGenix, Roche, and Lilly, with positions spanning from Clinical Research Physician to Director of Clinical Research. She has led various departments, managed global teams, and directed clinical trials across multiple therapeutic areas, including gastroenterology, immunology, cardiology, and pain management. Her strategic guidance has driven several landmark projects forward, including the advancement of microbiome and cell therapies from preclinical to first-in-human trials, demonstrating her expertise in transforming innovative therapies into viable treatment options.

🧬 Contributions and Research Focus

Dr. Gilaberte has made notable contributions to clinical research, particularly in stem cell therapy, immunology, and neuroscience. Her pioneering work on Darvadstrocel, an allogeneic adipose-derived mesenchymal stem cell therapy, led to significant strides in treating perianal fistulas and positioned her as a leader in regenerative medicine. She has been instrumental in launching global clinical trials, developing target product profiles (TPP), and submitting regulatory applications for FDA and EMA approvals. With a robust publication record, including 66 papers indexed in PubMed, she continues to contribute to scientific literature, sharing her findings and advancing the field of biomedicine.

🏆 Accolades and Recognition

Dr. Gilaberte’s excellence has been recognized through numerous awards across her roles in clinical development and leadership. Her achievements include multiple awards for her work in the clinical progression of innovative therapies and successful drug submissions to global regulatory bodies. She has received recognition for her strategic contributions to the Darvadstrocel trials and for advancing neuroscience programs in Alzheimer’s disease. Her leadership has earned her high regard in the industry, with acknowledgments from institutions and colleagues alike.

🌍 Impact and Influence

Dr. Gilaberte’s impact extends beyond her immediate professional roles. Her contributions to clinical science have enhanced treatment options for patients with complex diseases, and her leadership has shaped clinical strategies in multinational pharmaceutical companies. She has also promoted effective collaboration across global, cross-functional teams, fostering a diverse and inclusive work environment that prioritizes patient needs. Her initiatives in regulatory compliance, risk management, and data integration have set new standards for clinical operations, solidifying her influence as a thought leader in her field.

📜 Legacy and Future Contributions

Looking ahead, Dr. Gilaberte’s legacy is one of commitment to advancing patient care through innovation, collaboration, and strategic foresight. Her future endeavors are poised to make an enduring impact, with ongoing research and leadership contributions that will shape the future of clinical development. Her philanthropic work, such as building a nursery in Uganda, highlights her dedication to global well-being beyond her professional achievements. Dr. Gilaberte continues to inspire the next generation of clinical researchers, ensuring that her legacy of precision, empathy, and patient-first innovation will endure.

Publications

📄 Efficacy and Safety of Weekly Calcifediol Formulations (75 and 100 µg) in Subjects with Vitamin D Deficiency: A Phase II/III Randomised Trial

Authors: Esteban Jódar-Gimeno, Jose Luis Pérez-Castrillón, Ján Nociar, Michal Lojka, Dimitar Nikolov, Fernando Cereto-Castro, Snežana Novković, Umberto Tarantino, Nadia Mehsen-Cetre, Paula Arranz, Cristina Martínez Ostalé, Aintzane García-Bea, Inmaculada Gilaberte
Journal: Nutrients
Year: 2024

📄 Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial

Authors: Coimbra, J., Puntes, M., Molina, P., Arranz, P., Sánchez, C.
Journal: European Journal of Pharmaceutical Sciences
Year: 2024

📄 Bioequivalence and Safety of Bilastine 20 mg Orodispersible Tablets and Conventional Tablets: A Randomized, Single-Dose, Two-Period Crossover Study in Healthy Volunteers Under Fasting Conditions

Authors: Román, M., Ochoa, D., Martin, S., Arranz, P., Sánchez, C.
Journal: Drugs in R and D
Year: 2024

📄 Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn’s Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims Databases

Authors: Karki, C., Latremouille-Viau, D., Gilaberte, I., Romdhani, H., Lightner, A.L.
Journal: PharmacoEconomics
Year: 2023

📄 Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn’s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial

Authors: Garcia-Olmo, D., Gilaberte, I., Binek, M., Spinelli, A., Panés, J.
Journal: Diseases of the Colon and Rectum
Year: 2022

Jiang hua Yang | Medicine and Dentistry | Best Researcher Award

Posted on 19/07/202420/07/2024 by Book of Award

Dr. Jianghua Yang | Medicine and Dentistry | Best Researcher Award

Yijishan Hospital | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Jianghua Yang began his academic journey in the medical field with a focus on infectious diseases. His foundational studies laid the groundwork for a career dedicated to understanding and combating a variety of infectious diseases. Over the years, Dr. Yang has honed his expertise and developed a deep research interest in several key areas, including tuberculosis, severe fever with thrombocytopenia syndrome, schistosomiasis, and hepatitis.

Professional Endeavors

Dr. Jianghua Yang is currently associated with the Department of Infectious Diseases at Yijishan Hospital of Wannan Medical College in Wuhu, Anhui, China. In his professional role, he has undertaken significant research projects and contributed extensively to the field of infectious diseases. His work is characterized by a commitment to advancing medical knowledge and improving patient outcomes through rigorous scientific inquiry and collaboration with other researchers.

Contributions and Research Focus

Dr. Yang's research spans several critical areas in infectious diseases. His studies on tuberculosis have been published in reputable journals such as "Tuberculosis (Edinb)" and the "International Journal of Infectious Diseases". His work on severe fever with thrombocytopenia syndrome has appeared in the "Journal of Medical Virology" and the "Japanese Journal of Infectious Diseases". Additionally, Dr. Yang has investigated schistosomiasis, with his findings published in "Scientific Reports" and "Journal of Cancer". His research on hepatitis has been featured in the "European Journal of Gastroenterology & Hepatology" and "BMC Gastroenterology". These contributions have not only enhanced the understanding of these diseases but have also provided valuable insights into their diagnosis, treatment, and management.

Accolades and Recognition

Throughout his career, Dr. Yang has received recognition for his impactful research and contributions to the field of infectious diseases. His publications have been cited by peers, reflecting the significance and influence of his work. Dr. Yang's dedication to advancing medical science has earned him respect and acknowledgment within the academic and medical communities.

Impact and Influence

Dr. Yang's research has had a substantial impact on the understanding and treatment of infectious diseases. His work on tuberculosis and severe fever with thrombocytopenia syndrome has informed clinical practices and guided further research in these areas. By elucidating the complexities of diseases such as schistosomiasis and hepatitis, Dr. Yang has contributed to the development of more effective diagnostic and therapeutic strategies, thereby improving patient care and outcomes.

Legacy and Future Contributions

Dr. Jianghua Yang's legacy in the field of infectious diseases is marked by his significant research contributions and his commitment to advancing medical knowledge. As he continues his work, Dr. Yang is poised to make further groundbreaking discoveries that will enhance the understanding of infectious diseases and lead to better health outcomes worldwide. His ongoing research and dedication to scientific excellence will undoubtedly inspire future generations of researchers and healthcare professionals.

Notable Publications

Construction of an early differentiation diagnosis model for patients with severe fever with thrombocytopenia syndrome and hemorrhagic fever with renal syndrome 2024

Prevalence and impact of viral myocarditis in patients with severe fever with thrombocytopenia syndrome 2024

Clinicopathological characteristics and its association with digestive system tumors of 1111 patients with Schistosomiasis japonica 2023 (1)

A risk prediction model for acute kidney injury in patients with pulmonary tuberculosis during anti-tuberculosis treatment 2022 (4)

Hong Seok Kim | Medicine and Dentistry | Best Researcher Award

Posted on 01/07/202406/07/2024 by Book of Award

Dr. Hong Seok Kim | Medicine and Dentistry | Best Researcher Award

Seoul National University | South Korea

Author Profile

Scopus

Orcid

Early Academic Pursuits

Dr. Hong Seok Kim began his academic journey with a Bachelor of Science in Engineering from Johns Hopkins University (2007-2010). He then pursued a Doctor of Medicine (M.D.) at the College of Medicine, Seoul National University (2011-2015), followed by a Ph.D. from the Graduate School, Seoul National University (2020-2022).

Professional Endeavors

Dr. Kim's professional career is marked by a series of significant positions within the Department of Orthopaedic Surgery at Seoul National University Hospital. Starting as an intern in 2015, he progressed to a resident, fellow, clinical professor, and finally, assistant professor. His roles reflect a steady advancement in his expertise and responsibilities in orthopaedic surgery.

Contributions and Research Focus

Dr. Kim has made substantial contributions to orthopaedic surgery, particularly focusing on hip arthroplasty, osteonecrosis, sarcopenia, and periprosthetic joint infections. His research is well-documented through numerous publications in high-impact journals. He has explored various aspects of orthopaedic surgery, from the biomechanics of hip replacements to the management of complex fractures and the implications of sarcopenia in elderly patients.

Accolades and Recognition

Dr. Kim's work has been recognized with several prestigious awards, including:

Best Presentation Award from the Korean Sarcopenia Association (2021)
Manrye Award from the Korean Orthopedic Association (2021)
International Scholar Award from the Korean Hip Society (2022)
Multiple CiOS reviewer Awards from the Korean Orthopedic Association (2022, 2023)
Best Podium Award from the Korean Hip Society (2024)

Impact and Influence

Dr. Kim's influence extends beyond his clinical and research contributions. His involvement in various professional societies, such as the Korean Orthopedic Association, Korean Hip Society, and Korean Society for Bone and Mineral Research, underscores his commitment to advancing the field. His work has influenced clinical practices, particularly in the management of hip fractures and the use of novel implant designs in total hip arthroplasty.

Legacy and Future Contributions

Dr. Kim's legacy is built on his dedication to improving patient outcomes through innovative surgical techniques and rigorous research. As he continues to publish influential papers and participate in international collaborations, his future contributions are likely to shape the evolution of orthopaedic surgery, particularly in the areas of hip arthroplasty and the management of musculoskeletal conditions in the elderly.

Notable publications

Computed Tomography (CT) Evaluation of Alumina Ceramic-on-Ceramic Total Hip Arthroplasty with More than 20 years of Follow-Up: Is a Follow-Up CT Scan Necessary? 2024

Novel radiologic indices for stem type decision in total hip arthroplasty in patients with metaphyseo-diaphyseal mismatched Dorr A proximal femur 2024

Outcome and complication rate of total hip arthroplasty in patients younger than twenty years: which bearing surface should be used? 2024 (2)

Optimization of Acetabular Cup Abduction by Adjusting Pelvic Pitch 2024

A 10- to 12-year follow-up study of delta ceramic-on-ceramic total hip arthroplasty 2023 (5)

Nina Tuncel | Health Professions | Women Research Award

Posted on 07/02/202407/02/2024 by Book of Award

Assoc Prof Dr. Nina Tuncel | Health Professions | Women Research Award

Akdeniz University | Turkey

Author Profile

Scopus

Early Academic Pursuits

Assoc. Prof. Nina Tunçel began her academic journey with a solid foundation in physics at Al-Zahra University, Iran, where she completed her undergraduate studies from 1979 to 1987. She pursued postgraduate studies in Tıbbi Radyofizik at Istanbul University's Health Sciences Institute from 1988 to 1991, followed by a doctoral degree in the same field from 1991 to 1998. Her academic pursuits in physics laid the groundwork for her interdisciplinary research focus encompassing medicine, health sciences, and biophysics.

Professional Endeavors

Throughout her career, Assoc. Prof. Nina Tunçel has held various academic and professional positions, demonstrating her commitment to advancing knowledge and expertise in her field. She began as a Research Assistant at Istanbul University's Onkoloji Enstitüsü (Oncology Institute) from 1993 to 1996, marking the beginning of her involvement in medical physics research. Subsequently, she held positions as an Expert at Akdeniz University's Faculty of Medicine and Dokuz Eylul University's Tıp Fakültesi (Faculty of Medicine) , where she contributed significantly to radiation oncology and internal medicine.

Contributions and Research Focus

Assoc. Prof. Tunçel's research areas span a wide range of disciplines, including medicine, health sciences, internal medicine sciences, radiation oncology, physics, and interdisciplinary physics. Her expertise in biophysics and medical physics has led to numerous contributions in the understanding and application of radiation in healthcare, such as the design of tissue-mimicking gel phantoms for diffusion kurtosis imaging and the optimization of radiotherapy techniques for various cancer treatments. Her research has been published in prestigious journals indexed by SCI, SSCI, and AHCI, highlighting her significant contributions to the scientific community.

Accolades and Recognition

Assoc. Prof. Nina Tunçel has received recognition for her outstanding contributions to the field of medical physics. Her research has earned her accolades such as the Best Researcher Award, demonstrating the impact of her work on advancing knowledge and innovation in healthcare. Additionally, she has been acknowledged for her academic excellence through publications in renowned journals and presentations at international conferences, further solidifying her reputation as a leading expert in her field.

Impact and Influence

Assoc. Prof. Tunçel's work has had a profound impact on the field of medical physics, particularly in the areas of radiation oncology and biophysics. Her research has contributed to the development of innovative techniques and methodologies for cancer treatment, improving the effectiveness and precision of radiation therapy while minimizing adverse effects on patients. Through her academic endeavors and professional contributions, she has inspired future generations of scientists and clinicians to explore new frontiers in medical physics and contribute to the advancement of healthcare.

Legacy and Future Contributions

Assoc. Prof. Nina Tunçel's legacy lies in her significant contributions to the field of medical physics, which have paved the way for advancements in cancer treatment and radiation therapy. Her research has provided invaluable insights into the complex interactions between radiation and biological systems, leading to improved patient outcomes and quality of life. As she continues her academic journey, Assoc. Prof. Tunçel remains committed to pushing the boundaries of knowledge in medical physics and shaping the future of healthcare through her innovative research and dedication to excellence.

Notable Publications

Physical and chemical properties of beads glasses 2023

Radio-sensitivity on MCF-7 cells of silver nanoparticles synthesized by Silybum marianum 2023 (3)

Hybrid Tomo-Helical and Tomo-Direct radiotherapy for localized prostate cancer 2021 (1)

The dose rate measurements of C-arm fluoroscopic x-ray systems with and without apron 2018 (1)

Design and Characterisation of Tissue-Mimicking Gel Phantoms for Diffusion Kurtosis Imaging 2018 (17)

Tsheten Tsheten | Health Professions | Best Researcher Award

Posted on 01/02/202401/02/2024 by Book of Award

Dr. Tsheten Tsheten | Health Professions | Best Researcher Award

Australian National University | Australia

Author Profile

Orcid

Early Academic Pursuits

Dr. Tsheten began his academic journey with a Bachelor's in Allied Health Sciences from Sri Ramachandra University, India. He later pursued a Master of Public Health at Mahidol University, Thailand. His academic prowess led him to complete a Ph.D. in Epidemiology and Population Health at the Australian National University (ANU) in 2023.

Professional Endeavors

Dr. Tsheten has a rich professional background. Prior to his current role as a Research Fellow at the Population Health Exchange (PHXchange) at ANU, he served as an epidemiologist at the Royal Centre for Disease Control in Bhutan until 2019. His experiences include outbreak investigations, public health, and geospatial mapping.

Contributions and Research Focus

His research interests encompass infectious diseases, neglected tropical diseases, outbreak investigation, and geospatial mapping. Dr. Tsheten's significant contributions include risk mapping and socio-ecological drivers of soil-transmitted helminth infections. He is involved in dengue control strategies, spatial analysis of epidemiological data, and has presented at various international conferences.

Accolades and Recognition

Dr. Tsheten has received accolades such as the Dean's Rising Star Award at ANU. His research on risk mapping and socio-ecological drivers of soil-transmitted helminth infections in the Philippines has been recognized. He has secured multiple research grants and is actively engaged in peer-review activities for reputed journals.

Impact and Influence

As a Research Fellow, Dr. Tsheten plays a pivotal role in teaching and mentoring. He serves as a course convener, guest lecturer, and research supervisor. His influence extends to research mentoring for Ph.D. candidates and providing training to health researchers in Bhutan.

Legacy and Future Contributions

Dr. Tsheten's legacy lies in his comprehensive research portfolio, impactful publications, and significant contributions to public health in Bhutan. His future contributions are anticipated through ongoing research, mentoring, and endeavors to control diseases like dengue in the Asia-Pacific region.

Notable Publications

Risk mapping and socio-ecological drivers of soil-transmitted helminth infections in the Philippines: a spatial modelling study 2023

Impact of COVID-19 on mental health in Bhutan: a way forward for action 2023 (2)

A cross-sectional study to assess the epidemiological situation and associated risk factors of dengue fever; knowledge, attitudes, and practices about dengue prevention in Khyber Pakhtunkhwa Province, Pakistan 2022 (11)

Risk Factors of Symptomatic COVID-19 in Samtse District, Bhutan 2022 (3)

Yannick Allanore | Medicine and Dentistry | Best Research Article Award

Posted on 08/01/202408/01/2024 by Book of Award

Prof. Yannick Allanore | Medicine and Dentistry | Best Research Article Award

Université Paris Cité | France

Author Profile

Scopus

Early Academic Pursuits

Yannick Allanore commenced his academic journey at Paris Descartes University, obtaining a Master's degree in 1999, followed swiftly by a Medical Doctor certification in 2000. His commitment to specialization in Rheumatology led to a Certification in Rheumatology in 2001. His profound interest in the field culminated in a thesis on "Oxidative stress and systemic sclerosis," earning him a Physician Doctor title in 2004.

Professional Endeavors

His academic tenure unfolded as an Assistant Professor at Paris Descartes University's Rheumatology department at Cochin Hospital from 2005 to 2008. Allanore's research prowess was acknowledged with a Research Habilitation in 2005, focusing on the pathogenesis of systemic sclerosis. Subsequently, he served as a Post-doctoral researcher at INSERM U781 and U1016, delving into the genetic bases and chronic inflammation of systemic sclerosis.

Contributions and Research Focus

Allanore leads a groundbreaking research team at Institut Cochin, delving into pathogenesis and innovative therapies for fibro-inflammatory rheumatic diseases since 2018. His research delves into genetic and pathophysiological aspects of systemic sclerosis, cardio-pulmonary involvement, clinical trials, and endothelial progenitor cells in rheumatic diseases.

Accolades and Recognition

Professor Allanore boasts a substantial publication record, exceeding 480 papers in peer-reviewed journals, showcasing an impressive H-Index of 71. His contributions have earned him memberships in esteemed societies such as the French Rheumatology Society, American College of Rheumatology, and significant roles within EUSTAR and the World Scleroderma Foundation.

Impact and Influence

His leadership roles, including former chairman of EUSTAR and current vice-director of Institut Cochin, testify to his impact on the global rheumatology community. Allanore's multifaceted approach—integrating clinical research, genetic studies, cellular biology, and animal model platforms—underlines his comprehensive influence on understanding and treating chronic inflammatory rheumatic diseases.

Legacy and Future Contributions

Yannick Allanore's legacy lies in his pivotal contributions to unraveling the complexities of systemic sclerosis and related conditions. His leadership in research and academia continues to pave the way for innovative therapies and a deeper comprehension of these debilitating diseases. As vice-director of Institut Cochin, his ongoing dedication promises further advancements in the field of rheumatology.

Notable Publications

Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis 2023 (1)

Characteristics of patients with difficult-to-treat rheumatoid arthritis in a French single-centre hospital 2023 (2)

Comparison of subcutaneous and oral methotrexate initiation in rheumatoid arthritis in current practice 2023 (1)